AngelMed achieves first commercial implantation of cardiac detection monitor during outpatient procedure

  • Small
  • Medium
  • Large

Coronary diagnostics company AngelMed recently marked its first commercial implantation of its cardiac detection monitor in the U.S.

The FDA-approved Guardian system is a patient warning system used for acute coronary syndrome events, including silent heart attacks, according to a July 27 press release.

The device was implanted during an outpatient procedure performed by Andrew Kaplan, MD, at Cardiovascular Associates of Mesa in Arizona. Dr. Kaplan was a clinical trial investigator for the system and serves on the company's medical advisory board.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast